Medtronic (MDT) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Medtronic, Inc. (MDT) PT Raised to $100 at Evercore ISI, 'we find MDT compelling in a choppy macro environment'
May 25, 2023 11:15 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Medtronic, Inc. (NYSE: MDT) to $100.00 (from $88.00) while maintaining a Outperform rating.
The analyst comments "Generally, inlinish results (vs expecs) and Guide are not reasons to be cheeringbut given the uniqueness of MDT situation, we see the 4Q print as a clearing event and time for investors to get incrementally constructive. For background, MDT has had a tough 18 months, starting with the late 2021 triple whammy of Diabetes warning letter, RDN headline miss and pushout of robotics. This... More
Deutsche Bank Keeps Hold Rating on Medtronic, Inc. (MDT), 'Good, but maybe not quite good enough'
May 25, 2023 11:13 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Net-net. The debate heading into the quarter was simple: (1) What does 4Q results imply about guidance; (2) Is FY 2024 guidance a... More
